🇺🇸 FDA
Patent

US 11234992

Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides

granted A61KA61K31/7016A61K31/702

Quick answer

US patent 11234992 (Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides) held by The Regents of the University of California expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/7016, A61K31/702, A61K35/20, A61K45/06